| Fri, 07 Dec 2018 16:00:09: | AstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer
|
| Fri, 07 Dec 2018 15:16:54: | Tris Pharma recalls potentially harmful infants' ibuprofen
|
| Fri, 07 Dec 2018 14:13:41: | With pricing outcry raging, U.S. drug spending grew less than 1% last year: CMS
|
| Fri, 07 Dec 2018 13:27:57: | With Tesaro off the block, will Clovis be the next PARP maker to get swallowed up?
|
| Fri, 07 Dec 2018 13:21:56: | FiercePharmaAsia—Takeda-Shire finish line; Sun’s crisis; J&J-Legend CAR-T
|
| Fri, 07 Dec 2018 12:03:28: | Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck
|
| Thu, 06 Dec 2018 17:16:01: | Actelion inks $360M deal to resolve DOJ kickbacks probe
|
| Thu, 06 Dec 2018 16:22:51: | Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
|
| Thu, 06 Dec 2018 16:07:48: | Troubled Mallinckrodt spins off specialty generics business in ongoing effort to reshape its image
|
| Thu, 06 Dec 2018 15:41:28: | Big Pharma’s off-patent drugs lose out in China’s new price-cutting scheme
|
| Thu, 06 Dec 2018 15:33:27: | Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
|
| Thu, 06 Dec 2018 14:45:05: | Novartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3
|
| Thu, 06 Dec 2018 14:44:02: | Catalent is expanding and adding 36 jobs at its Indiana biologics plant
|
| Thu, 06 Dec 2018 04:59:56: | Sanofi plots 670 layoffs in France as local tensions brew
|
| Wed, 05 Dec 2018 23:13:19: | Roche's Tecentriq lines up for billion-dollar market with FDA priority tag
|
| Wed, 05 Dec 2018 17:29:10: | Novo keeps adding capacity, and jobs, to its North Carolina drug plant
|
| Wed, 05 Dec 2018 15:39:27: | AstraZeneca's Calquence found success in lymphoma. Will CLL follow?
|
| Wed, 05 Dec 2018 15:11:22: | Taking aim at Medicaid misclassifications like Mylan's EpiPen, senators look to end a 'pharma ripoff'
|
| Wed, 05 Dec 2018 14:40:05: | Chinese drugmaker pours $145M into plant with plan to produce innovative biologics
|
| Wed, 05 Dec 2018 07:56:23: | Mismanagement allegations send Sun Pharma stock tumbling: What we know so far
|
| Wed, 05 Dec 2018 02:41:55: | Sanofi merges biology and tech with research deal for digital asthma lab
|
| Tue, 04 Dec 2018 19:51:06: | As Amazon takes page from pharma's EHR playbook, smarter DTC could be on the way
|
| Tue, 04 Dec 2018 15:47:43: | Solicitor general to back Merck at Supreme Court in Fosamax pre-emption case
|
| Tue, 04 Dec 2018 15:45:02: | Ocular Therapeutix crosses finish line with eye treatment after running down production problems
|
| Tue, 04 Dec 2018 15:15:03: | ASH: Johnson & Johnson, AbbVie's Imbruvica steals the CLL spotlight with phase 3 study wins
|
